2,2,2-trifluoro-1-[4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]piperazin-1-yl]ethanone


Chemical Name: 2,2,2-trifluoro-1-[4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]piperazin-1-yl]ethanone
CAS Number: 1218789-87-7
Product Number: AG00168B(AGN-PC-07XUMB)
Synonyms:
MDL No:
Molecular Formula: C17H23BF3N3O3
Molecular Weight: 385.1890

Identification/Properties


Properties
Storage:
Keep in dry area;2-8℃;
Form:
Solid

Safety Information


GHS Pictogram:
N/A
Signal Word:
UN#:
-
Hazard Statements:
-
Precautionary Statements:
Class:
-
Packing Group:
-

NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



The compound 2,2,2-Trifluoro-1-(4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazin-1-yl)ethanone serves as a valuable tool in chemical synthesis, particularly in the realm of medicinal chemistry and pharmaceutical development. This intricate molecule, with its unique arrangement of trifluoro and boron functionalities, offers a versatile platform for the construction of novel organic compounds.In chemical synthesis, 2,2,2-Trifluoro-1-(4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazin-1-yl)ethanone can be utilized as a key building block in the creation of complex pharmaceutical agents and bioactive molecules. Its trifluoro group provides enhanced lipophilicity and metabolic stability, making it a valuable component in the design of drug candidates. Additionally, the boron-containing moiety enables facile functional group transformations through Suzuki-Miyaura coupling reactions, allowing for efficient diversification of chemical structures.Overall, the application of 2,2,2-Trifluoro-1-(4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazin-1-yl)ethanone in chemical synthesis empowers chemists to access a wide array of molecular architectures with potential therapeutic significance. Its strategic incorporation in synthetic pathways can lead to the discovery of innovative drugs and biologically active compounds with improved pharmacological profiles.